Effect of Estrogen Receptor Status on Circulatory Immune and Metabolomics Profiles of HER2-Positive Breast Cancer Patients Enrolled for Neoadjuvant Targeted Chemotherapy
- Supplementary File 1:
PDF-Document (PDF, 804 KiB)
Vignoli, A.; Muraro, E.; Miolo, G.; Tenori, L.; Turano, P.; Di Gregorio, E.; Steffan, A.; Luchinat, C.; Corona, G. Effect of Estrogen Receptor Status on Circulatory Immune and Metabolomics Profiles of HER2-Positive Breast Cancer Patients Enrolled for Neoadjuvant Targeted Chemotherapy. Cancers 2020, 12, 314. https://doi.org/10.3390/cancers12020314
Vignoli A, Muraro E, Miolo G, Tenori L, Turano P, Di Gregorio E, Steffan A, Luchinat C, Corona G. Effect of Estrogen Receptor Status on Circulatory Immune and Metabolomics Profiles of HER2-Positive Breast Cancer Patients Enrolled for Neoadjuvant Targeted Chemotherapy. Cancers. 2020; 12(2):314. https://doi.org/10.3390/cancers12020314
Chicago/Turabian StyleVignoli, Alessia, Elena Muraro, Gianmaria Miolo, Leonardo Tenori, Paola Turano, Emanuela Di Gregorio, Agostino Steffan, Claudio Luchinat, and Giuseppe Corona. 2020. "Effect of Estrogen Receptor Status on Circulatory Immune and Metabolomics Profiles of HER2-Positive Breast Cancer Patients Enrolled for Neoadjuvant Targeted Chemotherapy" Cancers 12, no. 2: 314. https://doi.org/10.3390/cancers12020314